ANKRD12: A Potential Drug Target and Biomarker (G23253)

Target Name: ANKRD12

NCBI ID: G23253

ANKRD12

ANKRD12: A Potential Drug Target and Biomarker

Ankyrin subfamily D nucleotide binding proteins (ANKRs) are a family of G protein-coupled receptors (GPCRs) that play a crucial role in cellular signaling. The ANKRD12 gene is a member of this family and has been identified as a potential drug target and biomarker. In this article, we will discuss the ANKRD12 protein, its function, potential drug targets, and its potential as a biomarker for various diseases.

Function and Localization

The ANKRD12 gene encodes a protein that consists of a catalytic N-terminus, a transmembrane region, and an N-terminal cytoplasmic domain. The protein has been shown to localize to the endoplasmic reticulum (ER) and to be predominantly expressed in the liver and spleen. It is also known to be involved in the regulation of cellular signaling pathways, including the T cell receptor signaling pathway.

Potential Drug Targets

The ANKRD12 protein is a potential drug target due to its unique structure and its involvement in cellular signaling pathways. Several studies have shown that ANKRD12 can be modulated by small molecules, including inhibitors of tyrosine kinase activity and modulators of ion channels. Additionally, ANKRD12 has been shown to play a role in the regulation of cellular signaling pathways, including the T cell receptor signaling pathway. Therefore, ANKRD12 may be a useful target for the development of new anti-cancer drugs.

Biomarker Potential

The ANKRD12 protein has been shown to be involved in the regulation of cellular signaling pathways, including the T cell receptor signaling pathway. Therefore, it has the potential to be used as a biomarker for the diagnosis and prognosis of various diseases. For example, ANKRD12 has been shown to be involved in the regulation of the T cell receptor signaling pathway, which is critical for the development and function of T cells. Therefore, ANKRD12 levels may be used as a biomarker for the diagnosis and prognosis of T cell-related diseases, such as cancer.

Conclusion

The ANKRD12 gene is a member of the Ankyrin subfamily D of GPCRs and has been shown to play a crucial role in cellular signaling pathways. Its unique structure and its involvement in the regulation of cellular signaling pathways make it a potential drug target and biomarker. Further research is needed to fully understand the function and potential of ANKRD12 as a drug target and biomarker.

Protein Name: Ankyrin Repeat Domain 12

Functions: May recruit HDACs to the p160 coactivators/nuclear receptor complex to inhibit ligand-dependent transactivation

The "ANKRD12 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ANKRD12 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets